オザグレル
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/02/13 13:27:42」(JST)
[Wiki en表示]
Ozagrel
|
Systematic (IUPAC) name |
(2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]acrylic acid |
Clinical data |
AHFS/Drugs.com |
International Drug Names |
Pregnancy cat. |
? |
Legal status |
℞ Prescription only |
Routes |
Oral |
Identifiers |
CAS number |
82571-53-7 Y |
ATC code |
None |
PubChem |
CID 5282440 |
UNII |
L256JB984D N |
KEGG |
D08327 Y |
ChEMBL |
CHEMBL11662 N |
Chemical data |
Formula |
C13H12N2O2 |
Mol. mass |
228.24 g/mol |
SMILES
- C1=CC(=CC=C1CN2C=CN=C2)C=CC(=O)O
|
N (what is this?) (verify)
|
Ozagrel (INN) is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor.[1]
References
- ^ Loo MH, Egan D, Vaughan ED, Marion D, Felsen D, Weisman S (March 1987). "The effect of the thromboxane A2 synthesis inhibitor OKY-046 on renal function in rabbits following release of unilateral ureteral obstruction". J. Urol. 137 (3): 571–6. PMID 3820396.
English Journal
- Synthesis, crystal structure, and properties of a double-helical zinc(II) coordination polymer with Ozagrel drug.
- Yang WC, Zheng ZB, Sun HL, Wang KZ.SourceCollege of Chemistry and Chemical Engineering, Pingdingshan University, Pingdingshan, Henan 467002, China.
- Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.Spectrochim Acta A Mol Biomol Spectrosc.2012 Feb;86:187-90. Epub 2011 Oct 20.
- By the reaction of Zn(OAc)(2)·2H(2)O with Ozagrel, (E)-3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylic acid (Himpaa), a novel coordination polymer [Zn(impaa)(2)](n)(1) was synthesized and was characterized by IR, elemental analysis, single-crystal X-ray diffraction analysis, photoluminescence spectro
- PMID 22078079
- Thromboxane A2 synthetase inhibitor plus low dose aspirin : can it be a salvage treatment in acute stroke beyond thrombolytic time window.
- An GH, Sim SY, Jwa CS, Kim GH, Lee JY, Kang JK.SourceDepartment of Neurosurgery, National Medical Center, Seoul, Korea.
- Journal of Korean Neurosurgical Society.J Korean Neurosurg Soc.2011 Jul;50(1):1-5. Epub 2011 Jul 31.
- OBJECTIVE: There is no proven regimen to reduce the severity of stroke in patients with acute cerebral infarction presenting beyond the thrombolytic time window. Ozagrel sodium, a selective thromboxane A2 synthetase inhibitor, has been known to suppress the development of infarction. The antiplatele
- PMID 21892396
- Fasudil and ozagrel in combination show neuroprotective effects on cerebral infarction after murine middle cerebral artery occlusion.
- Koumura A, Hamanaka J, Kawasaki K, Tsuruma K, Shimazawa M, Hozumi I, Inuzuka T, Hara H.SourceDepartment of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.
- The Journal of pharmacology and experimental therapeutics.J Pharmacol Exp Ther.2011 Jul;338(1):337-44. Epub 2011 Apr 14.
- Rho kinase (ROCK), one of the serine/threonine kinases, is involved in pathologic conditions, and its activation causes neuronal cell death. Fasudil, a selective ROCK inhibitor, has been reported to cause increased cerebral blood flow (CBF) in the ischemic brain and protect against neuronal cell dea
- PMID 21493751
Japanese Journal
- Isolated Shoulder Palsy due to a Cortical Infarction
- Tsuda Hiromasa,Kubota Yawara,Tanaka Kozue,Kishida Shuji
- Internal Medicine 50(8), 947-947, 2011
- NAID 130000650094
- A Selective Thromboxane A_2 (TXA_2) Synthase Inhibitor, Ozagrel, Attenuates Lung Injury and Decreases Monocyte Chemoattractant Protein-1 and Interleukin-8 mRNA Expression in Oleic Acid-Induced Lung Injury in Guinea Pigs
- ISHITSUKA Yoichi,MORIUCHI Hiroshi,ISOHAMA Yoichiro,TOKUNAGA Hidehiro,HATAMOTO Keita,KURITA Sumika,IRIKURA Mitsuru,IYAMA Ken-ichi,IRIE Tetsumi
- Journal of pharmacological sciences 111(2), 211-215, 2009-10-20
- NAID 10025739282
- 非心原性脳梗塞への抗血栓療法に関するEBMと薬剤選択(<特集>頭蓋内動脈狭窄症)
- 豊田 一則
- 脳神経外科ジャーナル 18(7), 494-501, 2009-07-20
- 急性期脳梗塞患者への抗血栓療法として,アスピリンの使用が強く勧められる.わが国のガイドラインでは,国産薬であるオザグレルナトリウムやアルガトロバンも勧められている.その一方で,臨床の場でよく用いられるヘパリンの有用性は確立していない.慢性期の非心原性脳梗塞患者への再発予防には,抗凝固薬でなく抗血小板療法が勧められる.具体的な推奨薬は各国のガイドラインで少しずつ異なるが,わが国で現在使用可能な薬剤の …
- NAID 110007333752
Related Links
- オザグレル塩酸塩水和物(Ozagrel hydrochloride hydrate)の検索ならお薬検索QLife(キューライフ)。お医者さんが処方する処方薬と、薬局で買える市販薬(OTC)、の効果と副作用、写真、添付文書、保管方法等を掲載。商品名だけでなく ...
- Find quality suppliers and manufacturers of Ozagrelfor price inquiry.where to buy Ozagrel.Also offer free database of Ozagrel including MSDS sheet(poisoning, toxicity, hazards and safety),chemical properties,Formula, density and ...
- Structure, properties, spectra, suppliers and links for: Ozagrel . ... Predicted data is generated using the US Environmental Protection Agency’s EPISuite , for more information see their website. Log Octanol-Water Partition Coef ...
Related Pictures
★リンクテーブル★
[★]
- 英
- ozagrel
- JAN
- 塩酸オザグレル ozagrel hydrochloride
- 化
- 塩酸オザグレル ozagrel hydrochloride、オザグレルナトリウム ozagrel sodium
- 商
- (塩酸オザグレル):ドメナン、ベガ
- (オザグレルナトリウム):アトロンボン、オキリコン、オザグレルNa、オザグレルナトリウム、オサグレン、オグザロット、オザペン、カタクロット、カタクロン、キサクロット、キサンボン、キサンボンS
- 関
- トロンボキサン合成酵素阻害薬。他に分類されない代謝性医薬品
分類
-
- →抗血栓薬の分類だが、血小板凝集抑制を目的とした適応はない、らしい?
作用機序
薬理作用
適応
[★]
オザグレルナトリウム
- 関
- ozagrel、ozagrel hydrochloride